Navigation Links
RoosterBio Launches Products to Streamline & Scale Production of Extracellular Vesicles

To radically simplify processes and increase productivity for researchers, RoosterBio Inc. has launched two bioprocess media products, RoosterCollect™-EV and EV Boost™, that supplement a scalable xeno-free manufacturing process to efficiently produce, collect, and boost human mesenchymal stem/stromal cell (hMSC)-derived exosomes and extracellular vesicles (EVs). By starting with a high-volume hMSC-specific process, customers can now catalyze a complete EV workflow within a tunable platform delivering marked savings in process time – which directly translates to accelerated development programs and cost savings.

Within the regenerative medicine industry, the exosome market is one of the fastest growing segments, exhibiting a compound annual growth rate (CAGR) of over 40%. MSCs are at the forefront of this growth as 50% of all stem cell-derived exosome/EV publications in 2018 were specific to MSCs. A cornerstone to today’s challenges related to therapeutic EV development has been industrializing EV platforms to make them more productive. RoosterBio is addressing the EV productivity challenge in two ways. First, they are helping EV product developers quickly achieve significant cell mass and efficient EV collection using RoosterBio’s cell and bioprocess media kits coupled with RoosterCollect-EV. This solution can be immediately implemented in 2D flask or 3D bioreactor culture systems. Secondly, RoosterBio has invented a patent pending product (EV Boost) designed to stimulate cells to increase EV production – driving massive EV productivity gains without scale up.

RoosterBio’s Founder & Chief Product Officer, Jon A. Rowley, PhD said, “The launch of these two products complement our hMSC bioprocess systems and provide a complete EV production solution enabling our customers to escape the ‘exosome bottleneck’, and rapidly get into the clinic with hMSCderived EVs made with efficient and scalable processes.” He added, “The product, system, and bioprocess are critical. If EV production is the issue, high quality cellular starting materials coupled with scalable processes are the solution.”

Pre-ordering for RoosterCollect™-EV and EV Boost™ is available now and will start shipping mid-March 2019. To find out more, visit

About RoosterBio, Inc.
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine technology :

1. RoosterBio Launches Large-Scale hMSC Banks to Simplify & Streamline Biomanufacturing
2. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
3. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
4. Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
5. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
6. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
7. Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
8. Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services
9. TMA Launches Physician Services Organization for Patient Care
10. Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions
11. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
Post Your Comments:
(Date:1/10/2020)... ... 2020 , ... By mid-January, many people’s New Year’s resolutions have fallen by the wayside. ... Night Wellness Retreat for the 2020 season. , Open each year from the last spring ... in May and the first weekend of October. The new dates for New Life Hiking ...
(Date:1/8/2020)... ... January 08, 2020 , ... E.M.M.A. International Consulting Group, Inc. ... the attainment of a national certification as a Women’s Business Enterprise by the ... Enterprise National Council (WBENC). , "We are so pleased to receive the National ...
(Date:1/8/2020)... PHOENIX (PRWEB) , ... January 09, 2020 , ... ... is now offering its partner practices a complimentary freezer program. The cryogenic freezer ... for procedures. , The top stem cell and exosome biologics require cryogenic freezing. ...
Breaking Medicine Technology:
(Date:1/23/2020)... ... January 23, 2020 , ... ... with memory impairment, has announced the Best Memory Care Facilities in Pensacola, Florida. ... facility features and amenities. , According to the Alzheimer’s Association , ...
(Date:1/23/2020)... ... 2020 , ... Dr. Dan Myers and The Dentist Centers Sandy Springs are ... professional dental staff. The Dentist Centers is a state-of-the-art family practice, offering ... and restorative dentistry, all in a relaxing, comfortable environment. , As a new addition ...
(Date:1/23/2020)... WASHINGTON (PRWEB) , ... January 23, 2020 , ... ... 2020 IRF Executive Committee and the IRF Board of Trustees. Representing all segments ... the foundation in meeting its mission of conducting research and providing education highlighting ...
(Date:1/22/2020)... ... January 22, 2020 , ... ... appointed Ilana Glazer as its new external relations director. In her role, ... relations, grants administration, external communications, community education, brand strategy, public policy, and ...
(Date:1/12/2020)... ... January 11, 2020 , ... The co-founder and CEO ... coinciding with the annual JP Morgan Healthcare Conference. On Sunday, January 12, Sujuan ... medical technology company investors and advisers at the San Francisco office of international ...
Breaking Medicine News(10 mins):